Indegene IPO listing: Shares make strong debut; list at 46% premium
The shares of Indegene listed at ₹659.70 on the BSE, against the IPO price of ₹452 per equity share.
The shares of Indegene listed at ₹659.70 on the BSE, against the IPO price of ₹452 per equity share.
In the January to March quarter of FY24, the revenue of operations of the auto platform stood at ₹145.27 crore, up 51.5%, as against ₹95.86 crore in the same period last year.
The county’s fourth largest small finance bank is reportedly planning to apply for the universal bank license by May-June 2025.
The company plans to merge Keimed, a promoter-owned wholesale pharma distribution business, with Apollo HealthCo over the next 24 to 30 months.
Ace investor and D-Mart founder and chairman Radhakishna Damani reportedly bought an additional 1.51% stake or 2.33 lakh shares of the company on April 15.
The beleaguered telecom operator plans to use ₹12,750 crore from the FPO to purchase equipment to expand its 4G and 5G network as well as existing capacities.
In the last nine months, the mcap of all BSE-listed companies increased by ₹100 lakh crore to cross ₹400 lakh crore marks for the first time ever.
The fair trade regulator Competition Commission of India (CCI) approved a 100% acquisition of Lanco Amarkantak Power Limited by the company on March 26.
Jupiter Wagons plans to invest an additional ₹1,000 crore over the next two years.
LIC says it has placed robust controlling mechanisms along with best practices to prevent any kind of front running